Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.

Suppr

超能文献

作者信息

Cohen M H, Broder L E, Fossieck B E, Ihde D C, Minna J D

出版信息

Cancer Treat Rep. 1977 May-Jun;61(3):489-90.

PMID:194694

Abstract

摘要

相似文献

Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.

Cancer Treat Rep. 1977 May-Jun;61(3):489-90.

[Phase II study of VP-16 in patients with primary bronchogenic carcinoma, with special reference to small cell carcinoma--a multi-institutional cooperative study].

Nihon Gan Chiryo Gakkai Shi. 1986 Feb 20;21(1):12-8.

Multicenter Phase II trial of etoposide in refractory small cell lung cancer.

Cancer Treat Rep. 1985 Jan;69(1):127-8.

[A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung].

Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 1):931-7.

[A phase II study of NK171 (etoposide)].

Gan To Kagaku Ryoho. 1985 Oct;12(10):2011-7.

[VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].

Schweiz Med Wochenschr. 1977 Jul 2;107(26):912-5.

[A phase II study of oral VP-16 in primary lung cancer].

Gan To Kagaku Ryoho. 1985 Sep;12(9):1801-7.

[Phase II study of etoposide in patients with lung cancer, with special reference to small cell carcinoma].

Nihon Gan Chiryo Gakkai Shi. 1986 Feb 20;21(1):108-11.

Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.

Cancer Treat Rep. 1979 Aug;63(8):1231-9.

[Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].

Med Clin (Barc). 1984 May 19;82(19):836-9.

引用本文的文献

Accelerated Coronary Artery Disease in a Patient With Advanced Lung Cancer: Interplay of Cancer, Inflammation, and Treatment Effects.晚期肺癌患者的加速性冠状动脉疾病：癌症、炎症与治疗效果的相互作用

Cureus. 2025 Jan 21;17(1):e77769. doi: 10.7759/cureus.77769. eCollection 2025 Jan.

Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells.抗癌药物依托泊苷对多能干细胞来源的人心肌细胞的细胞死亡机制。

Arch Toxicol. 2018 Apr;92(4):1507-1524. doi: 10.1007/s00204-018-2170-7. Epub 2018 Feb 3.

Cancer therapy and cardiotoxicity: the need of serial Doppler echocardiography.癌症治疗与心脏毒性：连续多普勒超声心动图检查的必要性。

Cardiovasc Ultrasound. 2007 Jan 25;5:4. doi: 10.1186/1476-7120-5-4.

Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.化疗药物的心脏毒性：发生率、治疗与预防

Drug Saf. 2000 Apr;22(4):263-302. doi: 10.2165/00002018-200022040-00002.

Safety and efficacy of intraperitoneal injection of etoposide in oil suspension in mice with peritoneal carcinomatosis.

Cancer Chemother Pharmacol. 1995;36(3):211-6. doi: 10.1007/BF00685848.

The podophyllotoxin derivatives VP16-213 and VM26.

Cancer Chemother Pharmacol. 1982;7(2-3):73-80. doi: 10.1007/BF00254525.

[Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)].依托泊苷（VP 16-213）——一种具有高抗肿瘤活性的鬼臼毒素衍生物（作者译）

Klin Wochenschr. 1981 Nov 2;59(21):1177-88. doi: 10.1007/BF01721212.

Cyclic alternating combination chemotherapy for small cell lung cancer.小细胞肺癌的周期性交替联合化疗

Cancer Chemother Pharmacol. 1984;12(3):190-3. doi: 10.1007/BF00256544.

Epipodophyllotoxin (VP16-213) in small cell carcinoma of the Bronchus resistant to initial combination chemotherapy.支气管小细胞癌中对初始联合化疗耐药的表鬼臼毒素（VP16 - 213）

Cancer Chemother Pharmacol. 1982;7(2-3):179-80. doi: 10.1007/BF00254544.

Clinical pharmacology of intracarotid etoposide.

Cancer Chemother Pharmacol. 1986;16(3):292-4. doi: 10.1007/BF00293995.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验